Modern Strategy for Preclinical Pharmaceutical R&D by David Cavalla

Modern Strategy for Preclinical Pharmaceutical R&D by David Cavalla

The emphasis on cost-effectiveness within the pharmaceutical industry has caused it to outsource some development work. This text addresses the advantages and disadvantages of collaborations between industrial research and development divisions and contract research organizations and universities.

David Cavalla is an expert on secondary uses for existing drugs, or drug repurposing. He currrently operates through his consultancy, Numedicus Ltd, having worked in drug repurposing for 15 years. Previously he was CEO of Arachnova, and prior to that held various senior positions in pharmaceutical drug discovery at GSK and Napp Research Centre. He has written widely on drug discovery strategy, and is the author of 70 published papers and patents.

SKU	Unavailable
ISBN 13	9780471971177
ISBN 10	0471971170
Title	Modern Strategy for Preclinical Pharmaceutical R&D
Author	David Cavalla
Condition	Unavailable
Binding Type	Hardback
Publisher	John Wiley & Sons Inc
Year published	1997-03-21
Number of pages	228
Cover note	Book picture is for illustrative purposes only, actual binding, cover or edition may vary.